C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 243/40 (2006.01) A61K 31/166 (2006.01) A61P 3/00 (2006.01) C07C 243/38 (2006.01) C07C 255/57 (2006.01) C07C 323/62 (2006.01)
Patent
CA 2603475
Novel acyl hydrazides of the formula (I), in which R1 - R9 have the meanings defined in claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonary hypertension, cardiovascular diseases and kidney diseases, and generally any types of fibroses and inflammatory processes.
L'invention concerne de nouveaux acylhydrazides de formule (I) dans laquelle R1 - R9 ont la signification indiquée dans la revendication 1. Ces nouveaux acylhydrazides constituent des inhibiteurs de la SGK et peuvent être utilisés pour le traitement de maladies liées à la SGK ainsi que des affections telles que le diabète, l'adiposité, le syndrome métabolique (dyslipidémie), l'hypertonie généralisée et pulmonaire, les maladies cardio-vasculaires et les maladies rénales, ainsi qu'en général tout type de fibroses et de processus inflammatoires.
Beier Norbert
Dorsch Dieter
Gericke Rolf
Klein Markus
Lang Florian
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Acyl hydrazides as kinase inhibitors, in particular for sgk does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl hydrazides as kinase inhibitors, in particular for sgk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl hydrazides as kinase inhibitors, in particular for sgk will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1614982